“Clarification to provide further understanding of the conduct and design of TROPIC: A Phase 3 trial of cabazitaxel versus mitoxantrone in patients with metastatic castration-resistant prostate cancer” (2016) Archivio Italiano di Urologia e Andrologia, 88(1), pp. 72–73. doi:10.4081/aiua.2016.1.72.